全文获取类型
收费全文 | 19044篇 |
免费 | 1324篇 |
国内免费 | 267篇 |
专业分类
耳鼻咽喉 | 435篇 |
儿科学 | 232篇 |
妇产科学 | 338篇 |
基础医学 | 3156篇 |
口腔科学 | 389篇 |
临床医学 | 1560篇 |
内科学 | 3694篇 |
皮肤病学 | 890篇 |
神经病学 | 1190篇 |
特种医学 | 1390篇 |
外科学 | 2417篇 |
综合类 | 54篇 |
一般理论 | 9篇 |
预防医学 | 516篇 |
眼科学 | 535篇 |
药学 | 1962篇 |
中国医学 | 293篇 |
肿瘤学 | 1575篇 |
出版年
2024年 | 5篇 |
2023年 | 113篇 |
2022年 | 420篇 |
2021年 | 859篇 |
2020年 | 413篇 |
2019年 | 581篇 |
2018年 | 679篇 |
2017年 | 585篇 |
2016年 | 847篇 |
2015年 | 1190篇 |
2014年 | 1314篇 |
2013年 | 1421篇 |
2012年 | 2072篇 |
2011年 | 1915篇 |
2010年 | 1199篇 |
2009年 | 910篇 |
2008年 | 1191篇 |
2007年 | 1042篇 |
2006年 | 941篇 |
2005年 | 797篇 |
2004年 | 588篇 |
2003年 | 510篇 |
2002年 | 417篇 |
2001年 | 112篇 |
2000年 | 86篇 |
1999年 | 76篇 |
1998年 | 57篇 |
1997年 | 37篇 |
1996年 | 24篇 |
1995年 | 17篇 |
1994年 | 25篇 |
1993年 | 17篇 |
1992年 | 13篇 |
1991年 | 16篇 |
1990年 | 11篇 |
1989年 | 13篇 |
1988年 | 15篇 |
1987年 | 12篇 |
1986年 | 12篇 |
1984年 | 12篇 |
1982年 | 6篇 |
1981年 | 8篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1975年 | 3篇 |
1974年 | 5篇 |
1972年 | 3篇 |
1969年 | 4篇 |
1962年 | 5篇 |
1961年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
11.
12.
Three‐Dimensional Echocardiographic Evaluation of Mitral Apparatus during Preload Manipulation in Patients with Hypertrophic Cardiomyopathy
下载免费PDF全文
![点击此处可从《Echocardiography (Mount Kisco, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Hyemoon Chung M.D. Ji Hyun Yoon M.D. Young Won Yoon M.D. Ph.D. Ji Young Chung B.N. Jung‐Joon Cha M.D. Jong‐Youn Kim M.D. Ph.D. Pil‐Ki Min M.D. Ph.D. Byoung‐Kwon Lee M.D. Ph.D. Bum‐Kee Hong M.D. Ph.D. Se‐Joong Rim M.D. Ph.D. Hyuck Moon Kwon M.D. Eui‐Young Choi M.D. Ph.D. 《Echocardiography (Mount Kisco, N.Y.)》2015,32(8):1261-1269
13.
14.
15.
Paclitaxel with Cisplatin as Salvage Treatment for Patients with Previously Treated Advanced Transitional Cell Carcinoma of the Urothelial Tract
下载免费PDF全文
![点击此处可从《Neoplasia (New York, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
16.
17.
A M S El-Eragi M E Hamid N S Saeed A H Ahmed K Lee Y-H Kook M M Mukhtar 《The international journal of tuberculosis and lung disease》2007,11(6):671-675
OBJECTIVES: To characterise mycobacterial clinical isolates based on amplification of the rpoB gene. SETTING: One hundred and thirty-five mycobacterial isolates cultured from suspected pulmonary tuberculosis (TB) patients were identified phenotypically. Molecular characterisation of the isolates was performed based on amplification of the rpoB gene, using duplex polymerase chain reaction (DPCR), PCR-restriction fragment length polymorphism (RFLP) and nested PCR-based sequence analysis techniques. RESULTS: The DPCR assay identified 129 of 135 (95.5%) clinical isolates as Mycobacterium tuberculosis complex species. Restriction enzyme analysis of the rpoB PCR product using Hind II identified 134 of the 135 (99.3%) isolates as M. tuberculosis complex, while nested PCR sequence analysis of the rpoB gene identified 133/133 examined isolates (100%) as M. tuberculosis species. No mycobacteria other than M. tuberculosis (MOTT) were detected among the studied isolates. CONCLUSION: DPCR, PCR/RFLP Hind II and nested PCR sequence analysis of the rpoB gene techniques showed comparable efficiency in the characterisation of Mycobacterium isolates. Nested PCR sequence analysis of the rpoB gene was superior to PCR/RFLP for characterisation of suspected M. tuberculosis isolates, while the DPCR technique showed less sensitivity. As PCR-RFLP requires less sophisticated laboratory facilities than nested PCR sequence analysis, it would be more appropriate to be adopted for accurate characterisation of mycobacteria in countries with a weak infrastructure. 相似文献
18.
19.
20.
Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy. 总被引:6,自引:0,他引:6
Joo Hyun Kang June-Key Chung Yong Jin Lee Jae Hoon Shin Jae Min Jeong Dong Soo Lee Myung Chul Lee 《Journal of nuclear medicine》2004,45(9):1571-1576
To evaluate the possibility of radionuclide gene therapy and imaging in hepatocellular carcinoma cancer, we investigated the iodine accumulation of a human hepatocellular carcinoma cell line, SK-Hep1, by transfer of human sodium iodide symporter (hNIS) gene. By targeting NIS expression in SK-Hep1, we could also investigate whether these cells concentrate 99mTc-pertechnetate and 188Re-perrhenate as well as 125I in vitro and in vivo. METHODS: The hNIS gene was transfected to human hepatocellular carcinoma SK-Hep1 cell lines using lipofectamine plus reagent. The uptake and efflux of 125I, 99mTc-pertechnetate, and 188Re-perrhenate were measured in the transfected and parental cells. Biodistribution was studied in nude mice bearing SK-Hep1 and SK-Hep1-NIS at 10 and 30 min and at 1, 2, 6, 16, and 23 h after injection of 125I, 99mTc- pertechnetate, or 188Re-perrhenate. In tumor imaging studies, the nude mice were intravenously injected with 188Re-perrhenate and imaged with a gamma-camera equipped with a pinhole collimator at 30 and 60 min after injection. The survival rate (%) was determined by the clonogenic assay after 37 MBq/10 mL (1 mCi/10 mL) 131I and 188Re-perrhenate treatment. RESULTS: SK-Hep1-NIS, stably expressing the NIS gene, accumulated 125I up 150 times higher than that of SK-Hep1. Iodine uptake of SK-Hep1-NIS is completely blocked by perchlorate. NIS gene transfection into SK-Hep1 also resulted in 112- and 87-fold increases of 99mTc-pertechnetate and 188Re-perrhenate uptake, respectively. Iodide efflux from SK-Hep1-NIS was relatively slow, with only 10% released during the initial 5 min, and 60% remained at 25 min. In the biodistribution study using SK-Hep1-NIS-xenographed mice, the tumor uptake of 125I, 188Re-perrhenate, and 99mTc-pertechnetate was 68.0 +/- 15.0, 46.2 +/- 9.1, and 59.6 +/- 16.2 %ID/g (percentage injected dose per gram) at 2 h after injection, respectively. After 188Re-perrhenate injection in SK-Hep1 and SK-Hep1-NIS-xenographed nude mice, whole-body images clearly visualized the SK-Hep1-NIS tumor, whereas the control tumor was not visualized. The survival rate (%) of SK-Hep1-NIS was markedly reduced to 46.3% +/- 10.1% and 28.9% +/- 5.2% after 37 MBq/mL (1 mCi/10 mL) 131I and 188Re-perrhenate treatment compared with the survival rates of the parental cells. These results demonstrated that SK-Hep1-NIS could be selectively killed by the induced 131I and 188Re-perrhenate accumulation through NIS gene expression. CONCLUSION: NIS-based gene therapy using beta-emitting radionuclides has the potential to be used in hepatocellular carcinoma management. 相似文献